494 related articles for article (PubMed ID: 15287725)
1. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
Becker L; Cook PM; Koschinsky ML
Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
[TBL] [Abstract][Full Text] [Related]
2. Baboon lipoprotein(a) binds very weakly to lysine-agarose and fibrin despite the presence of a strong lysine-binding site in apolipoprotein(a) kringle IV type 10.
Belczewski AR; Ho J; Taylor FB; Boffa MB; Jia Z; Koschinsky ML
Biochemistry; 2005 Jan; 44(2):555-64. PubMed ID: 15641780
[TBL] [Abstract][Full Text] [Related]
3. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100.
Gabel BR; Koschinsky ML
Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
[TBL] [Abstract][Full Text] [Related]
5. A ligand-induced conformational change in apolipoprotein(a) enhances covalent Lp(a) formation.
Becker L; Webb BA; Chitayat S; Nesheim ME; Koschinsky ML
J Biol Chem; 2003 Apr; 278(16):14074-81. PubMed ID: 12566443
[TBL] [Abstract][Full Text] [Related]
6. Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a).
Chitayat S; Kanelis V; Koschinsky ML; Smith SP
Biochemistry; 2007 Feb; 46(7):1732-42. PubMed ID: 17263558
[TBL] [Abstract][Full Text] [Related]
7. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a).
Ernst A; Helmhold M; Brunner C; Pethö-Schramm A; Armstrong VW; Müller HJ
J Biol Chem; 1995 Mar; 270(11):6227-34. PubMed ID: 7890760
[TBL] [Abstract][Full Text] [Related]
8. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
9. Ligand-induced conformational change of lipoprotein(a).
Fless GM; Furbee J; Snyder ML; Meredith SC
Biochemistry; 1996 Feb; 35(7):2289-98. PubMed ID: 8652569
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of apolipoprotein(a) inhibits kringle-associated lysine binding: the loss of intrinsic protein fluorescence suggests a role for tryptophan residues in the lysine binding site.
Hermann A; Laws WR; Harpel PC
Protein Sci; 1997 Nov; 6(11):2324-35. PubMed ID: 9385634
[TBL] [Abstract][Full Text] [Related]
11. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
[TBL] [Abstract][Full Text] [Related]
12. Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance.
Mochalkin I; Cheng B; Klezovitch O; Scanu AM; Tulinsky A
Biochemistry; 1999 Feb; 38(7):1990-8. PubMed ID: 10026282
[TBL] [Abstract][Full Text] [Related]
13. Bacterial expression and characterization of human recombinant apolipoprotein(a) kringle IV type 9.
Chung FZ; Wu LH; Lee HT; Mueller WT; Spahr MA; Eaton SR; Tian Y; Settimi PD; Oxender DL; Ramharack R
Protein Expr Purif; 1998 Jul; 13(2):222-8. PubMed ID: 9675066
[TBL] [Abstract][Full Text] [Related]
14. Comparative analyses of the lysine binding site properties of apolipoprotein(a) kringle IV types 7 and 10.
Rahman MN; Becker L; Petrounevitch V; Hill BC; Jia Z; Koschinsky ML
Biochemistry; 2002 Jan; 41(4):1149-55. PubMed ID: 11802713
[TBL] [Abstract][Full Text] [Related]
15. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.
Rader DJ; Cain W; Ikewaki K; Talley G; Zech LA; Usher D; Brewer HB
J Clin Invest; 1994 Jun; 93(6):2758-63. PubMed ID: 8201014
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formation.
Gabel BR; May LF; Marcovina SM; Koschinsky ML
Arterioscler Thromb Vasc Biol; 1996 Dec; 16(12):1559-67. PubMed ID: 8977462
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in human apolipoprotein(a) kringle IV-10 and coronary artery disease: relationship to allele size, plasma lipoprotein(a) concentration, and lysine binding site activity.
Simó JM; Joven J; Vilella E; Ribas M; Figuera L; Virgos C; Sundaram IM; Hoover-Plow J
J Mol Med (Berl); 2001 Jun; 79(5-6):294-9. PubMed ID: 11485023
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.
Anglés-Cano E; Rojas G
Biol Chem; 2002 Jan; 383(1):93-9. PubMed ID: 11928826
[TBL] [Abstract][Full Text] [Related]
19. Impact of apolipoprotein(a) isoform size heterogeneity on the lysine binding function of lipoprotein(a) in early onset coronary artery disease.
Simó JM; Joven J; Vilella E; Ribas M; Pujana MA; Sundaram IM; Hammel JP; Hoover-Plow JL
Thromb Haemost; 2001 Mar; 85(3):412-7. PubMed ID: 11307806
[TBL] [Abstract][Full Text] [Related]
20. Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.
Klezovitch O; Edelstein C; Scanu AM
J Clin Invest; 1996 Jul; 98(1):185-91. PubMed ID: 8690792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
